As shown in Fig. 4c, the BCKDHA mRNA level was significantly reduced in a dose-dependent manner upon JIB04 treatment only in EGFR-mutant NSCLC cells. This evidence concerns the gene BCKDHA and non-small cell lung carcinoma.